LVMH Q3 Revenue Rises 9%, Slowing from Post-pandemic Frenzy

Romee Strijd poses before Dior Spring/Summer 2024 Women's ready-to-wear collection show during Paris Fashion Week in Paris, France, September 26, 2023. (Reuters)
Romee Strijd poses before Dior Spring/Summer 2024 Women's ready-to-wear collection show during Paris Fashion Week in Paris, France, September 26, 2023. (Reuters)
TT

LVMH Q3 Revenue Rises 9%, Slowing from Post-pandemic Frenzy

Romee Strijd poses before Dior Spring/Summer 2024 Women's ready-to-wear collection show during Paris Fashion Week in Paris, France, September 26, 2023. (Reuters)
Romee Strijd poses before Dior Spring/Summer 2024 Women's ready-to-wear collection show during Paris Fashion Week in Paris, France, September 26, 2023. (Reuters)

Luxury goods bellwether LVMH reported a 9% rise in third quarter revenue on Tuesday, marking slower growth as inflation and economic turbulence dented shoppers' appetites for high end fashion.

LVMH, which owns labels including Louis Vuitton, Dior, Tiffany and Bulgari, said that revenue came to 19.96 billion euros ($21.16 billion), up 9% year-on-year, on an organic basis.

That was slightly below a Visible Alpha consensus for 11.5% growth.

The fashion and leather goods division, home to Louis Vuitton and Dior, recorded sales growth of 9%, compared to analysts' expectations for 10% growth.

LVMH is facing slowing demand for high end goods in the United States and Europe, where rising prices have prompted shoppers — especially younger generations — to pull back from a post-pandemic spending euphoria, while the recovery in China has been uneven.

LVMH is the first major global luxury firm to report earnings this quarter and gives investors an insight into what to expect from rivals. Hermes and Kering report on Oct. 24.

Investors have recently lowered their expectations for the luxury sector and around 96 billion euros has been knocked off the value of LVMH since April.

The French luxury group was last month unseated as Europe's most valuable listed company after a 2-1/2 year long reign by Danish drugmaker Novo Nordisk, which was boosted by the growth of anti-obesity drug Wegovy.



Puma Reports Q3 Sales Increase on Rising Running and Soccer Shoes Demand

The logo of German sports goods firm Puma is seen on a shoe after the company's annual news conference in Herzogenaurach February 20, 2014. (Reuters)
The logo of German sports goods firm Puma is seen on a shoe after the company's annual news conference in Herzogenaurach February 20, 2014. (Reuters)
TT

Puma Reports Q3 Sales Increase on Rising Running and Soccer Shoes Demand

The logo of German sports goods firm Puma is seen on a shoe after the company's annual news conference in Herzogenaurach February 20, 2014. (Reuters)
The logo of German sports goods firm Puma is seen on a shoe after the company's annual news conference in Herzogenaurach February 20, 2014. (Reuters)

German sportswear maker Puma on Wednesday reported a 5% rise in currency-adjusted sales for the third quarter as it sold more running and soccer shoes.

Quarterly currency-adjusted sales rose to 2.31 billion euros ($2.48 billion), broadly stable from a year earlier but short of the 2.36 billion euros expected by analysts, according to LSEG data, as negative effects from foreign exchange rates continued to weigh on the business.

Footwear sales were up 9.3%.

Demand for the recently relaunched Formula 1-inspired "Speedcat" shoe was strong, CEO Arne Freundt said in a statement.

The company confirmed its full-year outlook for currency adjusted revenue in mid single-digit percentage, and core profit (EBIT) of between 620 million to 670 million euros, citing a strong order book for the remainder of the year.